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Breaking In through
Critical Windows 
p,p´-DDE May Alter Fetal
Neurodevelopment
DDT has been widely used to control mosquito-
borne malaria since the late 1940s. The com-
pound and metabolites such as p,p´-DDE linger
in the environment for decades; even in areas
where DDT has been banned, these neurotoxic
chemicals are still detected in human blood, fat,
breast milk, and umbilical cord blood.
Researchers examined the possibility that prenatal
exposure to p,p´-DDE damages early neurodevel-
opment, and present the first evidence that expo-
sure during a critical window of development
adversely affects infant psychomotor develop-
ment.[EHP 115:435–439; Torres-Sánchez et al.].
From January 2001 to June 2005, 1,585 repro-
ductive-age women in the State of Morelos,
Mexico, where DDT had been used for malaria
control until 1998, were invited to join the
prospective cohort study. Each woman choosing to participate provid-
ed a blood sample and information about sociodemographic charac-
teristics, obstetric and gynecologic history, alcohol and tobacco use,
occupation, and previous pesticide use. 
Once a woman became pregnant, the researchers conducted in-
home visits each trimester to collect a blood sample and data on her
pregnancy, weight, and diet. After the woman gave birth, they evaluated
her child at 1, 3, 6, and 12 months of age, focusing
on health, feeding, growth, and cognitive and psy-
chomotor development. The researchers also tested
maternal intelligence and assessed the home envi-
ronment by observing factors such as parent–child
interaction and available toys. Data were available
for 244 mother–child pairs.
p,p´-DDE was detected in all maternal blood
samples. Concentrations were the highest in the
third trimester, but analyses revealed that only
first-trimester concentrations were associated with
impaired psychomotor development. This associa-
tion remained after controlling for maternal intelli-
gence and the home environment; breastfeeding
appeared to have a slight protective effect. 
A subset of 105 maternal blood samples were
also tested for lead. Because maternal lead concen-
trations were not available for all infants, lead
exposure could not be completely excluded as con-
tributing to effects correlated with first-trimester
p,p´-DDE exposure. However, the low negative
correlation between the two neurotoxicants made
it unlikely that the effects observed were either
amplified or masked by lead. There did not appear to be an associa-
tion between prenatal p,p´-DDE exposure and cognitive development.
These findings add to the growing evidence that DDT metabolites
in a mother affect her child’s psychomotor development during infan-
cy. The researchers suggest that prenatal p,p´-DDE exposure needs
further attention, even in countries where DDT has not been used for
decades. –Julia R. Barrett
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Carbon Concerns
Nanotubes Cause
Cardiovascular Damage
Lung deposition of single-wall carbon
nanotubes (SWCNTs), one of the most
commonly used materials in nanotech-
nology, is already known to cause local-
ized toxic effects. Now scientists have
demonstrated that such deposition also
leads to cardiovascular damage in mice,
including accelerated formation of ath-
erosclerotic plaques [EHP 115:377–382;
Li et al.]. The findings add to concerns
that exposure to SWCNTs could result
in systemic toxic effects.
The team conducted a series of
experiments, instilling SWCNTs into the lungs of mice. In an initial
screen for extrapulmonary effects, Ho1-luc reporter transgenic mice
were exposed to single SWCNT doses of 10 or 40 µg. Heme oxyge-
nase-1 (HO-1) gene expression, a biomarker of oxidative stress, was
activated in the animals’ lung, aorta, and heart tissue at 7 days post-
exposure, declining to control levels by day 28. This held with pul-
monary toxicity studies showing an early, transitory inflammatory
response.
The same dosing scheme was used in experiments with the com-
monly used C57BL/6 mouse, which showed dose-dependent aortic
mitochondrial DNA (mtDNA) damage at 7, 28, and 60 days post-
exposure. mtDNA is highly susceptible to oxidative damage, consid-
ered to be an initiating event in atherogenesis. Among the treatment
groups, glutathione and protein carbonyl levels—two other indicators
of oxidative stress—were also significant-
ly reduced and increased, respectively,
adding to the evidence that exposure to
SWCNTs can lead to oxidative insult.
Exposure to comparable doses of ultra-
fine carbon black particles in a control
group produced no such damage to aor-
tic mtDNA.
The group then tested the effects of
SWCNT exposure in ApoE-/- mice, a
widely used model of human atheroscle-
rosis. They exposed the mice to 20 µg of
SWCNTs once every other week for 8
weeks. Then the mice were fed either a
regular chow diet or a high-fat diet for
the first half of that period to induce the
elevated lipid concentrations that often
precede atherosclerosis. Although SWCNT exposure was not associat-
ed with changes in the animals’ lipid profiles, the exposed mice on the
high-fat regimen did exhibit accelerated plaque formation in the aorta
and brachiocephalic arteries compared with controls.
The researchers note that the cardiovascular effects resulting from
SWCNT exposure could be either direct, as a result of translocation of
particles from the lung into the systemic circulation, or indirect,
caused by the release of inflammatory mediators in the lung or by
altered pulmonary function (although no increase in several measured
inflammatory mediators was detected in the exposed animals).
Whichever mechanism may be at work, these data show that lung
deposition of SWCNTs, a possible workplace exposure scenario, can
cause systemic damage and may contribute to cardiovascular disease.
–Ernie Hood
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Worming their way in? SWCNTs may cause systemic toxicity.
Back tracks. Long-ago pesticide spraying
can still affect today’s children.Science Selections
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Metal Duo Damages Lungs 
Lead and Manganese in Fine Particulates
Extensive evidence indicates that fine particulates can damage
human lungs. But much remains unknown about exactly which
components of these particulates are to blame. In a small study of
Korean children, researchers have found that two metals, lead and
manganese, are among the substances likely at fault [EHP
115:430–434; Hong et al.].
To pin down the particulate culprits, the researchers evaluated 43
children who attended school on an island near Incheon City. The
island has low traffic density and indus-
trial emissions, but concentrations of fine
particulates 2.5 µm in diameter or small-
er were relatively high by U.S. standards,
perhaps owing to natural sources or dust
from China or Mongolia. The mean of
20.27 µg/m3 measured during the six-
week study period was about one-third
higher than the U.S. annual standard.
After an introductory period during
which the children (median age 10)
learned how to use a peak expiratory
flow meter to measure their lung func-
tion, each child used the device at three
fixed times every day. Meanwhile, the
researchers sampled fine particulates
every day on the roof of a building 2 km
from the school and analyzed the
concentration of five metals: aluminum, iron, lead, manganese, and
zinc. Previous studies have shown these metals might play either ben-
eficial or harmful roles when present in particulates.
The researchers also tested the children for polymorphisms of
GSTM1 and GSTT1. These two genes play a role in the function of
the enzyme glutathione S-transferase, which scavenges the damaging
reactive oxygen species created by some metals. In addition, they took
into account many other factors, including weather, day of the week,
sex, age, height, weight, asthma history, passive smoking exposure at
home, and socioeconomic status. They did not test for other metals,
acquire data on other lung-damaging pollutants (such as nitrogen
dioxide or ozone), or measure personal
fine particulate exposures.
Typical of Asian populations,
roughly half the children did not have
one gene or the other due to deletion.
The team found that lead and man-
ganese were linked with significant
reductions in peak expiratory flow rate,
regardless of whether a child had either
of the tested gene polymorphisms. The
three other metals had no significant
effects, even though they sometimes
were present at much higher concentra-
tions than lead and manganese. The
team acknowledges that additional
studies are needed to comprehensively
determine the impact of metals on the
respiratory system. –Bob Weinhold
Gotcha! In a study of Korean children scientists identified some
of the health-damaging components of fine particulates.
The Testosterone Test
Phthalate Inhibits Leydig Cell Aggregation
Testicular cancer and low sperm count are adult disorders, but evi-
dence increasingly suggests they have a fetal origin. Cryptorchidism
and hypospadias, apparent at birth, also appear linked to prebirth
events. According to the testicular dysgenesis syndrome (TDS)
hypothesis, all four disorders, which by some reports have become
more common in recent decades, partially stem from fetal abnormali-
ties in testosterone-producing Leydig
cells. An investigation now reveals that
di(n-butyl) phthalate (DBP) and its
metabolite monobutyl phthalate (MBP)
suppress testosterone production in rats
and primates [EHP 115:390–396;
Hallmark et al.]. Attempts to establish in
vitro models were unsuccessful, however.
In rats, prenatal exposure to DBP can
induce Leydig cell changes and TDS-like
effects. Chronic, low-level exposure to
DBP and other phthalates, widely used as
plasticizers, is common among humans,
but it is unknown if it causes the same
effects. The primary goal of the current
study was to determine whether effects
seen in rats could be replicated in vitro
with fetal rat and human testis explants
(extracted tissue maintained in culture).
The team also conducted experiments in male infant marmosets,
whose neonatal testosterone production mirrors that of human males.
Preliminary work revealed that rats with prenatal DBP exposure
produced significantly less testosterone and had more medium or
large Leydig cell clusters. This is notable because larger clusters are
associated with defective testicular development. Rat fetal testis
explants, however, showed only minor MBP-related effects, and
results from comparable human explants were even less conclusive. 
Because known in vivo reactions could not be replicated in vitro—
indicating either a problem with the method or misidentification of
the active metabolite—the team tested MBP in marmosets. In five sets
of marmoset twins, one twin
was exposed to MBP for two
weeks while the other served as
a control. Blood testosterone
levels did not differ signifi-
cantly, but Leydig cell num-
bers and size were consistently
increased in the MBP group. 
Because low testosterone
triggers increased secretion of
luteinizing hormone, which
stimulates Leydig cell testosterone produc-
tion, the researchers checked whether
there was an initial MBP-associated sup-
pression in testosterone production. They
found that a single dose of MBP in new-
born marmosets significantly reduced
testosterone levels within hours. This find-
ing led to the hypothesis that increased
luteinizing hormone secretion compen-
sates for an initial MBP-associated inhibi-
tion of testosterone production, which the researchers conclude should
be considered in future animal studies. They also conclude that in vivo
marmoset research represents the best current means for investigating
the steroidogenic effects of DBP relevant to humans. –Julia R. Barrett
Testicular effect. The numbers and size of Leydig cells (in
brown, above) increased in MBP-treated marmosets. 